Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 13–13 | Cite as

Abacavir/lamivudine//rilpivirine

Various toxicities: 15 case reports
Case report
  • 19 Downloads

Reference

  1. Galizzi N, et al. Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load. PLOS One 13: e0191300, No. 2, Part A, 16 Feb 2018. Available from: URL: https://doi.org/10.1371/journal.pone.0191300.t002 - ItalyCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations